HAA Annual Scientific Meeting

Eadie, L. (Participant)

Activity: Other


White DL, Saunders VA, Eadie LN, Yeung, D, Hughes TP.
The depth of in vivo kinase inhibition achieved over the first month of nilotinib therapy predicts for subsequent molecular response and is closely related to nilotinib plasma levels.
Oral Presentation, Presidential Symposium
Gold Coast, Queensland
Period20 Oct 201323 Oct 2013